Labcorp Holdings Inc. (NYSE:LH) entered into an agreement to acquire Select Assets of MAWD Pathology Group, P.A.
The expected completion of the transaction is in early 2025. The transaction is subject to customary closing conditions.
USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
246.49 USD | +0.66% |
|
+0.09% | +7.49% |